Category: Medications - Page 3

Mar

Medications

Using Copay Cards Safely: Access Without Compromising Care

Copay cards can make life-saving medications affordable-but hidden insurance rules like accumulator programs can leave patients facing thousands in unexpected costs. Learn how to use them safely and avoid treatment disruption.

William Blehm

Mar

Medications

How to Use Patient Assistance Programs When No Generic Medication Exists

When no generic version of a medication exists, patient assistance programs can cover 100% of the cost-turning $15,000-a-month drugs into $0 out-of-pocket expenses. Learn how to apply, who qualifies, and how to avoid hidden traps like accumulator policies.

William Blehm

Mar

Medications

Long-term safety studies: comparing generics and brands over time

Long-term safety studies show generics are generally as safe as brand-name drugs, but critical differences exist for narrow therapeutic index medications. Manufacturing origin and individual response matter more than brand vs. generic labels.

William Blehm

Feb

Medications

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents

Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market faster. Under the Hatch-Waxman Act, this system has saved U.S. consumers over $1.2 trillion since 1990.

William Blehm

Feb

Medications

Opioid Withdrawal Timeline and How to Manage Symptoms Effectively

Opioid withdrawal symptoms peak within 72 hours and can last up to two weeks, depending on the drug. Medications like buprenorphine and methadone reduce symptoms by up to 70%, and medical supervision cuts relapse risk. Learn the timeline and science-backed strategies to manage withdrawal safely.

William Blehm

Feb

Medications

Proton Pump Inhibitors and Antifungals: How They Interfere With Absorption and Effectiveness

Proton pump inhibitors can severely reduce the absorption of some antifungals like itraconazole and ketoconazole, leading to treatment failure. Fluconazole is unaffected by stomach pH, but interactions with liver enzymes still matter. Emerging research shows PPIs may even boost antifungal power in resistant infections.

William Blehm

Feb

Medications

Tiered Copays: Why Your Generic Drug Might Cost More Than Expected

Your generic drug might cost more than the brand name because of how insurers tier medications. It’s not about quality - it’s about rebates. Here’s why and what to do about it.

William Blehm

Feb

Medications

How Medicare Drug Price Negotiation Works and What It Means for Your Costs

Medicare is now negotiating drug prices for the first time, cutting costs by up to 79% on 10 top medications starting in 2026. Here's how it works, who it helps, and what's coming next.

William Blehm

Feb

Medications

How Generic Drugs Save Billions in the U.S. Healthcare System

Generic drugs saved $482 billion in the U.S. in 2024 alone, making them the most powerful tool to control rising drug costs. Learn how generics and biosimilars cut spending, why brand drugs remain expensive, and what’s blocking even bigger savings.

William Blehm

Feb

Medications

Theophylline Levels: Why NTI Monitoring Is Critical for Safe and Effective Treatment

Theophylline has a narrow therapeutic window where too little fails and too much kills. Regular blood monitoring is essential to avoid toxicity and ensure effectiveness in asthma and COPD treatment.

William Blehm

Feb

Medications

Deprescribing Frameworks: How to Safely Reduce Medications and Cut Side Effects

Deprescribing safely reduces unnecessary medications to cut side effects, especially in older adults. Learn how frameworks like Shed-MEDS and STOPP/START help doctors and pharmacists cut pill burden without risking health.

William Blehm

Feb

Medications

Tentative Approval for Generics: Common Reasons for Delays

Tentative approval from the FDA means a generic drug is scientifically ready - but legal, manufacturing, or market barriers often prevent it from ever reaching patients. Here’s why delays happen and who’s affected.

William Blehm